Monday, January 28, 2019

[ASAP] Targeted Co-delivery of the Iron Chelator Deferoxamine and a HIF1a Inhibitor Impairs Pancreatic Tumor Growth

TOC Graphic

ACS Nano
DOI: 10.1021/acsnano.8b08823
ancac3?d=yIl2AUoC8zA


from Journals via hj on Inoreader http://bit.ly/2FSLgAt

No comments:

Post a Comment

Collaboration request

Hi there How would you like to earn a 35% commission for each sale for life by selling SEO services Every website owner requires the ...